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Summary: Neither resting nor stimulated isolated human polymorphonuclear leukocytes did bind or ingest
preformed complexes of arprpteinase Inhibitor and unlabeled/125I-labeled human leukocyte elastase. In
contrast, granulocytes bound unlabeled/125I-labeled elastase and the extent of binding was reduced in the
presence of respirätory burst stimulators, such äs 4ß-phorbol 12ß-myristate 13a-acetate, E. coli endotoxin,
and N^formyl-jL-methionyl-L-leucyl-L-phenylalanine. In association/dissociation and competition Inhibition
experiments it was demonstrated that granulöcyte^-elastase binding was specific and saturable. From Scatchard
and non-linear regression analysis there was evidence of a two-class receptor model with independent binding
sites. Calculated by the non-linear regression method assuming a two-class receptor model the characteristics
of the high affinity/low capacity binding site were K! = 216 ± 129 · l O6 l · mol"1 (x ± s; n = 3) and Rj =
1.38 ± 0.95 nmol · 1~* corresponding to 0.083 · 106 receptors per cell, whereäs the low affinity/ high capacity
binding site had the characteristics K2 = 0.50 ± 0.09 - 106 l-mol^1 and R2 = 237 ± 103 nmol · l"1
corresponding to 14.3 + 6.2 - 106 receptors per cell.
Untersuchungen zur Elastase* und a,i~Proteinaseinhibitor-Elastase-Aufnahme polymorphkerniger Leukocyten
und Nachweis eines Elastaserezeptor^Systems
Zusammenfassung: Komplexe aus -Proteinaseinhibitor und unmarkierter/markierter humaner Leukocyten-
Elastase werden von isolierten menschlichen polymorphkernigen Leukocyten weder unter Ruhe- noch unter
Stimulations-Bedingungen aufgenommen. Dagegen binden Granulocyten Elastase/[125I]Elastase, wobei die
[125I]Elastase-Bindung in Gegenwart der respiratory burst-Stimulantien 4ß-Phorbol-12ß-myristat-13a-acetat,
E. co/rVEndotoxin und Formyl-methionyl-leucyl-phenylalanin erniedrigt ist. Aus Assoziations-/Dissoziations-
und Kompetitions-Inhibitions-Experimenten geht hervor, daß die Granulocyten-Elastase-Bindung spezifisch
und sättigbar ist. Scatchard- und nichtlineare Regressions-Analyse deuten auf ein zweiklassiges Modell
unabhängiger Rezeptoren hin. Aus der nichtlinearen Regressionsanalyse ergeben sich unter Annahme eines
zweiklassigen Rezeptormodelis die Bindungskonstanten Kj = 216 ± 129 · l O61 · mol'1 (x ± s; n = 3) und Rj
= 1,38 ± 0,95 nmol · l"1 entsprechend 0,083 · l O6 Rezeptoren pro Zelle für die hochaffine/niedrigkapazitive
Bindungsstelle, während die niedrigaffine/hochkapazitive Bindungsstelle die Konstanten K2 = 0,50 ± 0,09
• 106 l -mol-1 Und R2 « 237 ± 103 nmol · l^1 entsprechend 14,3 ± 6,2 · 106 Rezeptoren pro Granulocyt
besitzt.
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Introduction
As with other cells of the mononuclear phagocytic
System human alveolar macrophages are able to en-
docytose proteins and protein complexes by mem-
brane receptor mediated processes. Thus, human neu-
trophil leukocyte elastase äs well äs a2-macroglobul·
in-elastase complexes are pinocytosed and phago-
cytosed, respectively, by alveolar macrophages, sug-
gesting that at least some of the elastase activity
found in macrophages may be ingested rather than
formed de novo (1—4). A previous report from this
laboratory presented evidence that bronchoalveolar
lavage-derived human granulocytes accumulate ap-
preciable amounts of arproteinase inhibitor-elastase
complexes during passage across the blood-air barrier
(5). In compartments such äs the interstitial space
where <X2-macroglobulin is likely to be present only
in low concentrations (1) elastase clearance must be
supposed to pccur predominantly via complex forma-
tion with a^proteinase inhibitor and elimination by
the reticuloendothelial System cells.
The present work was undertaken to clarify whether
granulocytes could provide an additional pathway
for uptake and elimination of elastase and/or ar
proteinase inhibitor-elastase complexes, thus giving
this cell a protective role in particular pathophysiol-
ogical situations additionally to its known dangerous
release reactions during Stimulation (6 — 8). Uptake
of [125I]elastase/elastase and a^proteinase inhibitor-
[125]elastase/elastase complexes by isolated human
polymorphonuclear leukocytes was investigated
under non-stimulation conditions and during respir-
atory burst Stimulation with soluble and particulate
substances. arProteinase inhibitor-elastase complex
ingestion was estimated by nephelometrically meas-
ured extracellular decrease of the complex concenträ-
tion äs well äs cellular radioactivity increase by em-
ployment of [125I]labeled elastase. In vitro binding of
elastase to human granulocytes for association and
dissociation experiments äs well äs for receptor stud-
ies was determined by the use of [125I]elastase.
Materials and Methods
Reagents and equipment
Fresenius, Bad Homburg, FRG: sodium citrate solution
(31.3 g/l)
Pharmacia Fine Chemicals, Uppsala, Sweden: Percoll for den-
sity gradient centrifugation; columns PD-10 Sephadex G-25 M
Boehringer, Mannheim, FRG: phosphate buffered saline Dul-
becco; Minimal Essential Medium Dulbecco for chemilumines-
cence without Phenol Red, without glutamine
E. Merck, Darmstadt, FRG: Türk's solution (acetic acid gentian
violet solution) for leukocyte counting; sodium Chloride; Triton
X-100; dimethylsulphoxide; monosodium phosphate · H2O; di-
sodium phosphate -2H20; sodium iodide; tris^hydroxy^·
methyl)aminomethane; N-2-hydroxyethyl-piperazine-Ni-2r
ethanesulphonic acid
Sigma Chemical Co. St. Louis, MO, U. S. A.: arantitrypsin,
from human plasma, partially purified; aibumin, bovine frac-
tion V, 96-99%; zymosan A from cerevisiae yeast; chlor-
amine T, trihydrate, crystalline; sodium bisulphite (sodium
metabisulphite), grade I; 4ß-phorbol 12ß-myristate 13a-acetate;
N-fonnyl-L-niethionyli-L-leücyl-L-phenylalanine; lipopolysac-
charide from E. coli serotype No. 055: B5, phenol extract
Bachern, Bubendorf, Switzeriand: methoxysuccinyl-j?>Ala-jL-
Ala-L-Pro-Z/Val-p-nitroanilide
Blood bank, Medizinische Hochschule Hannover, FRG: venpus
blood from male blood donors anticoagulated with 31.3 g/l
sodium citrate solution (9 vol of blood 4- l vol of citrate
solution); AB plasma, nonnal plasma from a AB/Rh pos blood
donor
Immuno Diagnostika GmbH, Heidelberg, FRG: anti-human-
apantitrypsin from goät; immunoneph Reference Standard
Human Proteins; immunoneph Norm Control Human Proteins;
Immuno-Video-Nephelometer; polyethylene glycol buffer con-
centrate, 400 g/l
Amersham Buchler GmbH + Co KG, Braunschweig, FRG:
Iodine-125, iodide, carrier-free, 100 Ci/1, 3.7 TBq/1
Laboratorium Prof. Dr. Berthold, Wildbad, FRG: multi-cfystal
gamfna counter LB 2100
Isolation of human polymorphonucleär leukocytes
Polymorphonuclear leukocytes were isolated from venous
blood of donors anticoagulated by the addition of 31.3 g/l
sodium citrate solution (9 vol of blood + l vol pf citrate
solution). In a slightly modified Hjorth's procedure (9) 4 ml
were layered on a two-step discöntinuous Percoll gradient
(densities of 1.077 and 1.095 g/cm3) in a 13 ml polystyrene tube
and centrifuged at 400 g at 22 °C for 20 min. Granulocytes
were harvested, washed twice with phosphate buffered saline
by centrifugation (600 g for lO^min at 22 °C), resuspended with
200^500 of minimal essential medium buffer solution and
counted using a Neubauer haemocytometer after cell staining
with Türks solution.
c^-Proteinase inhibitor-elastase complex formation
Elastase/aj-proteinase inhibitor titration
A stock solution of human ttj-proteinase inhibitor (2 g/l saline
solution, 0.154 mol/1) was diluted with minimal essential me-
dium buffer solution containing bovine serum albumin, l g/l,
to give concentrations of 3.125; 6.25; 12.5; 25.0 and 50.0 rng/1
,-proteinase inhibitor. From each of these Solutions, an aliquot
of 150 was mixed with 150 of elastase solution1) (3.72
mg/1 elastase in minimal essential medium buffer solution with
bovine serum albumin, l g/l) and incubated for 30 min at 22 °C.
Non-complexed elastase was determined enzymatically äs fol-
löws: 800 of buffer solution (0.1 mol/1 N-2-hydroxyethyl-
piperazine-N-2^ethanesülphonic acid, 2 mol/1 sodium chloride,
0.5 g/l Triton X-100, pH 8.0) were mixed with 100 of sample
(above reaction mixtures) and 100 ]1 of methoxysuccinyl--L·:
Ala-jL-Ala-L-Pro-L-Val-p-nitroanilide solution (2 g/l dimethyl-
sulphoxide) and the absorbance was recorded at 405 nm and
25 °C. l unit of elastase activity was defined äs the Substrate
turnover of l /min under the test conditions employed.
Huinan leukocyte elastase (9.3 g/l elastase, Charge XXIII, in
0.02 mol/1 acetic acid/0.15 mol/1-sodium chloride, pH 5.5,
frozen at -70°C) was a gift from Dr. S. 'Neumann, E.
Merck, Darmstadt, FRG.
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arProteinase inhibitor-elastase (i : i) complex formation
300 μΐ of arproteinase inhibitor solution (283.2 mg/1 minimal
essential medium) were incubated with 300 μΐ of elastase solu-
tion (36.8 mg/1) for 30 min at 22 °C, then diluted l : 8 with
minimal essential medium buffer solution with bovine serum
albumin, l g/l, to give a 20 mg/1 solution of the formed at-
proteinase inhibitor-elastase complex.
Opsonisation of zymosan
l g of zymosan A was incubated with 20 ml of AB plasma at
37 °C for 30 min, centrifuged (800g at 22 °C for 10 min),
washed twice with phosphate-buflered saline, once with mini-
mal essential medium buffer solution, resuspended in minimal
essential medium buffer, 50 g/l, and frozen in aliquols at
-70°C.
Phagocytosis experiments with arproteinase in-
hibitor-elastase complex
Phagocytosis experiments were done with a granulocyte Suspen-
sion (14.7 · 109/1 minimal essential medium buffer solution with
bovine serum albumin, l g/l), arproteinase inhibitor-elastase
solution (20 mg/1), Suspension of opsonized zymosan (50 g/i)
and minimal essential medium buffer solution with bovine
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After incubation at 37 °C for 60 min the reaction mixtures were
centrifuged (12000g at 22 °C for 4min) and the supernatauts
were analysed nephelometrically for dj-proteinase inhibitor-
elastase concentrations.
Nephelometrical determination of aj-proteinase in-
hibitor-elastase
apProteinase inhibitor-elastase complex concentrations were
determined by employment pf the reagent sets, protocols and
instrumentation pf Immuno Diagnostika GmbH for the deter-
mination pf arproteinase inhibitor.
lodination of human leukocyte elastase and enzyme
activity
A modificatipn pf the chloramine T inethod of Greenwood &
Hunter, (10) and Fink & G ttel (l 1) was used to iodinate human
leukocyte elastase. All reagents were dissolved in 0.05 mol/1
sodium phosphate buffer solution, pH 7.5. To 20 μΐ of diluted
Na125I solution (6.7 μΟί, 247.9 KBq) 5 μΐ of elastase solution
(2 g/l) and 5 ul of chloramine T solution (5 g/l) were added and
mixed. After 60 s at 22 °C, 50 μΐ of sodium bisulphile solution
(1.2 g/l) and 200 μΐ of sodium iodide solution (4.8 g/l in
phosphate buffer containing bovine serum albumin, 10 g/l)
were added, the reaction mixture was applied to a column PD-
10 (Pharmacia) and [125I]elastase was eluted with buffer solution
(0.1 mol/1 tris-(hydroxymethyl) aminomethane hydrochloride,
0.5 mol/1 sodium Chloride, bovine serum albumin, 10 g/l, pH
7.5) in 500 μΐ fractions with an elution rate of about l ml/min.
Fractions 8 — 10 showed peak radioactivity corresponding to
the elution volume of elastase. They were pooled to give a
concentration of 7.5 mg/1 [125I]elastase; the specific radioactivity
was 0.24 Ci/g, or 8.88 GBq/g. The biological activity of [125I]e-
lastase was tested by titration with at-proteinase inhibitor s
described above.
aj-proteinase in-Phagocytosis experiments with
hibitor-[125l]elastase complex
arProteinase inhibitor-[125I]elastase complex was formed by
incubation of 480 μΐ of [125I]elastase solution (7.5 mg/1) and
240 μΐ of arproteinase inhibitor solution (139 mg/1) for 20 min
at 22 °C. Using this solution, phagocytosis experiments were
performed s follows: (volumes in microliters)
incubation mixtures
1 2 3 4
granulocyte Suspension
(20.6 · 109/1)




minimal essential medium with
bovine serum albumin, l g/l
150 150 - -
10 - 10 -
150 150 150 150
10 150 160
After 30 min at 37 °C the tubes were centrifuged at 12000g
for l min at 22 °C, the supernatants were separated s quantita-
tively s possible, the remaining cell pellets were washed four
times with each 500 μΐ of minimal essential medium (with
bovine serum albumin, l g/l), then the cell pellets were resu-
spended in minimal essential medium with bovine serum albu-
min, l g/l, and transferred into a second tube by rinsing the
original tube another two times each with 200 μΐ of minimal
essential medium with bovine serum albumin, l g/l (to deter-
mine radioactivity adsorption in the original tube) and centri-
fuged; the supernatants were discarded, 500 μΐ of water were
added (to lyse the eells for the determination of incorporated
radioactivity); centrifuged and the supernatants separated from
the Sediments. All supernatants, cell pellets and Sediments were
analysed for radioactivity by a multi-channel gamma counter.
Granulocyter[125I]elastase binding
Binding of [125I]elastase by stimulated and non-stimulated gran-
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opsonized zymosan (12.5 g/l)
4 -phorbol 12 -myristate 13a-*cetate (35 μπιοΐ/ΐ)
N-fonnyl-methionyl-leucyl^henylalanine (100 μιηοΐ/ΐ)
endptoxin (413 mg/1)
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After incubation at 37 °C for 30 min with gentle agitation, the
reaction mixtures were centrifuged (2000 g, 22 °C, 5 min), a 300
μΐ aliquot of the supernatant was removed, 600 μΐ of minimal
essential medium (with bovine serum albumin, 2 g/l) were added
to the cell pellet, resuspended by vortexing and centrifuged
under the above conditions. This washing procedure was re-
peated three times. Then the cell pellet was resuspended with
600 μΐ of minimal essential medium (with bovine serum albu-
min, 2 g/l) and transfered into a second tube by rinsing the
original tube another two times each with 200 μΐ of minimal
essential medium with bovine serum albumin, 2 g/l (to deter-
mine the adsorption of [125I]elastase on to the tube surface).
After Sedimentation of the cells by centrifugation and removing
the supernatant, 800 μΐ of water were added (to lyse the cells
for the determination of incorporated radioactivity), centri-
fuged and the supernatant was separated from the sediment.
All supernatants, cell pellets and Sediments were analysed for
radioactivity.
After 0, 5, 10, 20, 30, 60, and 120 min, 5 ml of the Suspension
were centrifuged at 2000 g for 2 min. Several l ml aliquots of
the supernatant were analysed for radioactivity and their mean
was referred to the mean of a replicate measurement of several
aliquots of (i) and (ii), respectively, without centrifugation, s
fraction 1.0 reference values.
. · r
Calculation of the [125I]elastase dissociation was performed
according to the formula:
fraction of dissociation =
_ t min
counts/mintotal - co nts/min8upertatanl at 0 mi„
_ counts/minsupernatantat 0 mm _
counts/inintotal - counts/minsupe,batantat0min
Association and dissociation of [125I]elastase and
granulocytes
Association of [125I]elastase (9.29 Ci/g, 344 GBq/g, from another
iodination procedure) and isplated human polymorphonuclear
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[125I]elastase solution (24 mg/1)
elastase solution 1 (930 mg/1)















Incubation was performed at 24 °C with gentle agitation. At
times 0, 5, 10, 20 and 30 min, 200 μΐ were transferred into
13ml polystyrene tubes and total radioactivity was measured
for l min. After subsequent addition of 10 ml of prechilled
(4 °C) phosphate-buffered saline solution (with bovine serum
albumin, 2 g/l) the tubes were centrifuged at 2000 g for 2 min,
the supernatants were removed totally by suction, the radioac-
tivity of the cell pellets was measured and the fraction of
[125I]elastase bound to granulocytes was calculated. Dissocia-
tion experiments were performed s follows: after a preceeding
association experiment by incubation of 2 ml of granulocyte
Suspension (10 · 109/1) and 80 μΐ of [12SI]elastase (24 mg/1) at
24 °C for 30 min, [125I]-elastase binding was determined by
dilution of 100 μΐ of the incubation mixture with 10ml of
prechilled (4 °C) phosphate-buffered saline solution (with bov-
ine serum albumin, 2 g/l), centrifugation at 2000 g for 2 min,
removal of the supernatant and radioactivity counting of the
cell pellet. The radioactivity of 100 μΐ of the incubation mixture
served s the fraction 1.0 reference value. Then the incubation
mixture was centrifuged at 2000 g for 5 min, the supernatant
was removed and the cell pellet was rinsed with the original
volume of phosphate-buffered saline solution (with bovine
serum albumin, 2 g/l) at 4 °C. After centrifugation at 2000 g
for l min the supernatant was removed and the cell pellet was
resuspended with the original volume of ice-cold phosphate-
buffered saline solution (with bovine serum albumin, 2 g/l).
Each 500 μΐ of this Suspension were diluted
(i) with 50 ml of phosphate-buffered saline solution (with bov-
ine serum albumin, 2 g/l) and
(ii) with 50 ml of phosphate-buffered saline solution (with
boyine serum albumin, 2 g/l) and 30 μΐ of elastase solution (9.3
g/l) and kept at 24 °C with gentle agitation.
fraction of [125I]elastase binding = l .0 — fraction of dissocia-
tion.
Competition Inhibition experiments
Receptor characteristics were evaluated according to the follow-
ing scheme:
Before pipetting any reagent all tubes were rinsed with 10 ml of
phosphate-buffered saline (with bovine serum albumin, 2 g/l),
which was carefully removed by suction (to avoid adsorption
of elastase onto the vessel wall). All experiments were done in
duplicate in conical 12ml polystyrene centrifugation tubes.
1. elastase solution (0.03 — 312.6 μιηοΐ/ΐ) in 40 μΐ
minimal essential medium with bovine serum
albumin, 2 g/l
2. [125I]elastase solution (37.5 nmol/1 and 9.3 40 μΐ
Ci/g, 344.1 GBq/g)
total radioactivity counting
3. granulocyte Suspension (7.1; 11.2; 15.5 · 109/1) 300 μΐ
in minimal essential medium with bovine
serum albumin, 2 g/l
After incubation at 24 °C for 40 min with agitation 10 ml of
ice-cold phosphate-buffered saline solution (with bovine serum
albumin, 2 g/l) were added and the tubes were centrifuged at
2000 g for 2 min. For radioactivity counting of the supernatant
one 500 μΐ aliquot was withdrawn, then the supernatant was
removed by suction except for a remaining volume of 100 ίμΐ
including the cell pellet, which was also counted. Calculation
of the fraction of [125I]elastase binding was performed according
to the formula:
fraction of binding = counts/minsed — 0.2 · counts/minsi
counts/mintotal
radioactivity of the cell pellet including 100
μΐ of the supernatant
counts/minsup = radioactivity of 500 μΐ of the supernatant
counts/mintotal = total radioactivity of the reaction mixture
The fraetion of binding was normalized for 10 · 109/1 granulocy-
tes in the incubation mixture.
Calculation of receptor characteristics
In a first approach elastase receptor afimity and concentration
were calculated by employment of the Scatchard plot (12).
Spe'cific binding was calculated from total binding values by
subtraction of the ηόη-specific binding determined in the pre-
sence Of the highest concentration v f uniabeled elastase. Then
B/F ratios were calculated and plotted versus the corresponding
J. Clin. Chem. Clin. Biochem. / Vol. 24,1986 / No. 5
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concentrations of bound elastase. The receptor System could
be described by two straight lines of different slopes (Khigh amnity
and Klowaniniiy) and abscissa intercept points (Riowcapadty and
*Miigh capacity/·
The binding sites per cell were calculated by:
binding sites per cell '· 6.023'10
23-mol/lbound
cell count/1
In a second approach the binding parameters were extracted
by Iteration using a non-linear regression analysis for a one-
class äs well äs for a two-class receptor model according to 1. c.
(13), whereby Iteration was started with constants determined





Equilibriuin titration of elastase with arproteinase
Inhibitor resulted in a arprotemase inhibitor: elastase
ratio of 7.7 : l for total Inhibition of elastase activity
(fig. l)·
Phagocytosis experiments with aj-protein-
ase inhibitor-elastase complex
The results of the phagocytosis experiments show
that there was no uptake by polymorphonuclear leu-
kocytes of the preformed arproteinase inhibitor-elas-
tase complex, either by resting or by zymosan-stimu-
lated granulocyfes (tab. 1).
60
20
0 0.84 3.36 6.72
• Oj-Proteinase Inhibitor
Elastase ft]
Fig. 1. Human leukocyte elastase enzyme activity in depend-
ence on the ocj-proteinase inhibitor/elastase ratio deter-
mined under equilibrium conditions.
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Tab. 1. Phagocytosis experiments (37 °C, 60 min) with ocrpro-
teinase inhibitor-elastase complex (9.52 mg/1 = 6.0
mg/1 oq-proteinase inhibitor) and granulocytes (7 · 109/1)
in the absence and presence (2.38 g/l) of opsonized

























lodination of elastase and the enzymatic ac-
tivity of [125I]elastase
The determination of the -proteinase inhibitor/
[125I]elastase Inhibition interrelationship demon-
strated a slight increase of the biological activity
caused by iodination in comparison to the non-iodin-
ated compound; the arproteinase inhibitor/elastase
ratio for complete Inhibition under equilibrium con-










0 2 ^ 6 7 . 7
g t-P rotein äse inhibitor Tg"
[12Sl] Elastase f
Fig. 2. [125I]Elastase enzyme activity in dependence on the ocr
proteinase inhibitor/[12SI]elastase ratio determined
under equilibrium conditions.
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Phagocytosis experiments with at-protein-
ase inhibitor-[125I]elastase complex
By employment of the radiolabeled arproteinase in-
hibitor-[125I]elastase complex, cellular uptake and
non-specific adsorption of the complex were investi-
gated. The results are shown in figure 3. In compari-
son with the particle-bound radioactivity after the
fourth washing step, it could be demonstrated that
the presence of zymosan increased the particle-bound
radioactivity (granulocytes + zymosan) to a fraction
of about 0.03, whereas only 0.01 —0.015 were found
in the absence of zymosan; furthermore, most of this
portion resulted from radioactivity adsorption onto
the vessel wall, äs shown by the data for T, L, and
A in figure 3. From the experiments with granulocytes
and arproteinase inhibitor-[125I]elastase complex, it
was calculated that less than 0.003 of the radioactivity
fraction was bound by granulocytes, indicating the
absence of arproteinase inhibitor-[125I]elastase com-










Figure 4 shows [1?5I]elastase binding by isplated gran-
ulocytes under stiiiiulating and non-stimulating con-
ditions. In the presence of the* solüble Stimuli, 4ß^
phorbol 12ß-myristate 13a-acetate, E. coli endotoxiri
and N-formyl-methionyl-leucyl-phenylalanine, cellu-
lar binding ranged from 0.07 to 0.13 after the fourth
washing step, whereas in the absence of any Stimulus
the binding was found to be 0.145. The data observed
after further cell treatment (procedures T and L)
äs well äs the low adsorption valües (fractions of
0.0039—0.0074) indicated that [125I]elastase was
highly bound by granulocytes, presumably in a spe-
cific manner. From binding experiments with zymo-
san, an extremely high [*?5I]elastase binding to zymo-
san was seen, which was rarely altered in the presence
of granulocytes, thereby indicating that strong ad-
sorptive forces of zymosan and elastase surpass any
influence of granulocytes.
After:
incubation Kwashing 2.washing 3.washing 4.washing transfer lysis adsorption








transfer into a second tube
water lysis in the second tube and
remaining radioactivity of the original tube (adsorption).
Granulocytes Zymosan arProteinase inhibitof/[125I]elastase
D
B
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incubation l.washing Z.washing 3.washing 4.washing transfer lysis adsorption
Fig. 4. Binding of [125I]elastase (2.06 mg/1) to granulocytes (5.8 · 109/1) in the absence and presence of zymosan (l .79 g/l), 4 -phorbol
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water lysis in the second tube and







4 -phorbol 12 -myristate 13a-acetate
N-formyl-methionyl-leucyl-phenylalanine
E. coli endotoxin
Association and dissociation of [125I]elastase
and polymorphonuclear leukocytes
Association of p5I]elastase and granulocytes without
and with different atnounts of unlabeled elastase gave
typical association kinetics s shown in figure 5. After
a preceeding association of granulocytes and
[125I]elastase, dissociation experiments were per-
formed at 24 °C by l : 100 dilution of the granulocyte
Suspension and following incubation with and
without addition of an excess of unlabeled -elastase
(fig. 6). By dilution alone only weak and slow disso-
ciation. could be observed, wWch was hardly en-
hanced in the pi;esence of unlabeled elastase, thus
providing strong evidence for elastase-specific recep-
tor binding sites on the granulocyte surface, but
without site-site interactions s in the case of negative
cooperatively acting receptor sites (14).
Coriipetition Inhibit ion experiments
Results from competition Inhibition experiments with
is lated granulocytes of three blood donors on dif-
ferent days were obtained according to the calcula-
tion procedures described in section 'Materials and
Methods'.
(i) Plotting B/F ratios versus b (concentration of
bound [125I]elastase/elastase in nmol/1) gave Scatchard
plots of the same behaviour in that they could be
divided into two strictly defined straight lines assum-
ing two independent binding sites, one of high affinity
(KO, low capacity (RO, and another of low affinity
(K2), high capacity (R2) (fig. 7). Computer assisted
estimation of the binding parameters K and R was
performed according to Schwarz (15), taking into
account the mutual influences of the two regression
lines.
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Fig. 5. Association kinetics of granulocytes (12.2 · 109/1) and
[125I]elastase (0.2 mg/1) without and with unlabeled elas-
tase (19.4 mg/1 and 194 mg/1, respectively) at 24 °C.
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Fig. 6. Dissociation kinetics of [125I]elastase from granulocytes
at 24 °C by 1:100 dilution without and with an excess of
unlabeled elastase (for experimental details see section
'Materials and Methods')
o 1:100 dilution
o 1:100 dilution + unlabeled elastase
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Fig. 7. Scatchard plots of three competition Inhibition experi-
ments with granulocytes and [12SI]elastase/elastase.
Ordinate: B/F ratio
abscissa: concentration of [125I]elastase/elastase bound
in nmol/1.
(ii) By employment of a non-linear regression analysis
(13) and by using the constants estimated from the
Scatchard analysis äs starting conditions for the Itera-
tion, the binding characteristics were extracted separ-
ately for a one-class äs well äs for a two-class binding
model. Data are shown in table 2. The competition
Inhibition curves following Iteration are given in
figure 8.
Discussion
During migration of stimulated and phagocytosing
polymorphonuclear leukocytes from the capillary
vessel into the alVeolar space they increase their con-
tent of ai-proteinase inhibitor-elastase considerably
(5). The aim of the present inve^tigatipn was to deter-
mine whether ai-proteinase inhibitor-elastase com-
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• mol-1) (nmol · l"1) (receptors, (IO6 1 · mol-1) (nmol · l-1) (receptors,
106percell) 106percell)
19.8 1.2
2.2 0.13 0.40 285 17.2
52.3 3.2
1.6 0.1 0.56 307 18.5
32.6 2.0
0.34 0.02 0.54 118 7.1
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Fig. 8. Competition Inhibition curves from non-linear regression analysis for a one-class model (left side) and a two-class model
(right side).
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plexes or free elastase with secondary complexation
are ingested by granulocytes. From the results it is
clear that neither resting nor stimulated granulocytes
can take up arproteinase inhibitor-elastase/
[125I]elastase complexes. These fmdings are in agree-
ment with Dolovich et al. (3) and Campbell et al. (2)
who described an uptake by macrophages of protein-
ase-a2-macroglobulin but not of proteinase-aj-pro-
teinase inhibitor complexes. Surprisingly, [125I]ela-
stase was bound by granulocytes that commonly
secrete this enzyme if stimulated. In comparison with
the ctj-proteinase inhibitor-elastase complex, [125I]e-
lastase alone was bound to a considerably higher
extent, and this binding was inhibited or depressed
in the presence of the respiratory burst stimulators,
4ßphorbol 12ß-myristate 13a-acetate, E. coli endo-
toxin, and N-formyl-methionyl-leucyl-phenylalanine.
This may be explained by release of elastase (initiated
by the respiratory burst) from granulocytes into the
cell environment and competition with [125I]elastase
for binding to granulocytes, thus causing a decrease
of cell-bound [125I]elastase. These observations led üs
to the assumption of specific elastase binding sites
on the granulocyte surface, which we were able to
demonstrate by association and dissociation experi-
ments äs well äs competition Inhibition experiments.
From the dissociation experiments one can conclude
that only a small portion of negatively cooperating
site-site interactions may exist, if at all, and the data
from the Scatchard plot could be interpreted accord-
ing to the speculation of two independently operating
elastase receptor populatiöns. To further substantiate
this assumption we tried to calculate the binding
characteristics from the experimental data without
subtraction of non-specific binding by non-linear re-
gression methods. It was observed that a better fit of
the experimental data was achieved by employment
of the binding model with two independent receptor
sites rather than by the use of a one-class model. The
data for the low affinity/high capacity äs well äs
for the high affinity/low capacity binding site are
in agreement for the two-class non-linear regression
procedure and the Scatchard calculation.
In conclusion, polymorphonuclear leukocytes possess
a specific elastase receptor System on their surface,
the biological significance of which reinains to be
elucidated. Presumably, the elastase receptor can act
to bind and inactivate extracellularly released enzyme
and/or receptor-bound enzyme can be internalized
and then bound to a^proteinase inhibitor. Both
mechanisms should provide for the elimination of
elastase and in that granulocytes can act äs prötective
cells by partially deactivating the injurious elastolytic
potential in the cell environment produced by extra->
cellular elastase release in particular pathophysiologi-
cal circumstances, like highly stimulated phago-
cytosis.
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